182 related articles for article (PubMed ID: 8388741)
1. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis.
Seitz R; Rappe N; Kraus M; Immel A; Wolf M; Maasberg M; Egbring R; Pfab R; Havemann K
Blood Coagul Fibrinolysis; 1993 Apr; 4(2):249-54. PubMed ID: 8388741
[TBL] [Abstract][Full Text] [Related]
2. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
[TBL] [Abstract][Full Text] [Related]
3. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
Nagayama M; Tachibana A; Hayakawa H; Sato A
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
[TBL] [Abstract][Full Text] [Related]
4. Evaluating prethrombotic state in lung cancer using molecular markers.
Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
[TBL] [Abstract][Full Text] [Related]
5. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of an activation of coagulation in lung cancer.
Seitz R; Heidtmann HH; Wolf M; Immel A; Egbring R
Ann Oncol; 1997 Aug; 8(8):781-4. PubMed ID: 9332686
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
8. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer.
Matsuyama W; Hashiguchi T; Mizoguchi A; Iwami F; Kawabata M; Arimura K; Osame M
Chest; 2000 Oct; 118(4):948-51. PubMed ID: 11035661
[TBL] [Abstract][Full Text] [Related]
10. Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?
Steinbrueckner BE; Steigerwald U; Keller F; Neukam K; Elert O; Babin-Ebell J
Heart Vessels; 1995; 10(1):46-53. PubMed ID: 7730247
[TBL] [Abstract][Full Text] [Related]
11. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of coagulation assays in lung cancer.
Tas F; Kilic L; Serilmez M; Keskin S; Sen F; Duranyildiz D
Respir Med; 2013 Mar; 107(3):451-7. PubMed ID: 23200643
[TBL] [Abstract][Full Text] [Related]
13. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of hemostatic parameters in patients with lung cancer.
Unsal E; Atalay F; Atikcan S; Yilmaz A
Respir Med; 2004 Feb; 98(2):93-8. PubMed ID: 14971870
[TBL] [Abstract][Full Text] [Related]
15. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
17. [Coagulation and fibrinolysis in pregnancy].
Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
[TBL] [Abstract][Full Text] [Related]
18. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
19. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.
Masago K; Fujita S; Mio T; Togashi Y; Kim YH; Hatachi Y; Fukuhara A; Irisa K; Sakamori Y; Mishima M
Med Oncol; 2011 Mar; 28(1):351-6. PubMed ID: 20300980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
